Scientist II, Assay Development

  • Full-time

Company Description

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360®, Guardant360 CDx and GuardantOMNI® tests for advanced stage cancer patients. These tests fuel development of its LUNAR program, which aims to address the needs of early-stage cancer patients with neoadjuvant and adjuvant treatment selection, cancer survivors with surveillance, asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.

Job Description

To enable Guardant Health to lead the disruption of cancer treatments through non-invasive cancer screening, the Technology Development Team is seeking a highly motivated Scientist II to help develop and optimize novel assays and NGS technologies for oncology diagnostics and treatment selection. At Guardant, we leverage the most advanced technologies and work with leaders in many fields to create the most impactful and meaningful technologies for cancer management.

As a Scientist II in the Technology Development Team, you will work collaboratively with members from the team and interface cross-functionally with bioinformatics, process engineering, system engineering, as well as collaborate with other assay development teams. You will be hands on in the lab to evaluate and optimize new assays related to liquid biopsy sequencing technologies for the detection, treatment, and monitoring of all cancer types. You will play a critical role in the design and implementation of our advanced cancer diagnostics product as well as future product offerings.

Duties and Responsibilities

●       Assess, optimize, and implement cutting-edge research and technologies in molecular oncology and diagnostics to improve assay performance

●       Identify areas for improvement in current assays and propose and implement solutions

●       Collaborate within Technology Development and cross-functionally with bioinformatics as well as other cross-functional teams to facilitate effective execution of product goals

●       Be highly committed to deliver results in a fast-paced and rapidly growing organization

●       Document technical evaluations and provide SOPs as needed

●       Present data, proposals, and progress in various forums

Qualifications

●       PhD degree in molecular biology, biomedical sciences, or related field with 2+ years of industry work or post-doc experience

●       Experience in research, development and/or optimization of NGS technologies with strong preference for experience with cell-free nucleic acids

●      Strong data analysis skills with experience with Python or R and the experience in handling large datasets

●       Detail orientated with demonstrated ability to organize, document and communicate scientific data

●       Committed team player; enjoys working both independently and collaboratively in a fast-paced environment and able to adapt to change.

●       Strong underlying curiosity and drive

●       Sense of humor is a must

Additional Information

Covid Vaccination Policy: Starting January 7, 2022, Guardant Health will require all employees to be fully vaccinated to either (a) establish that they have been fully vaccinated against COVID-19; or (b) request and obtain an approved exemption from Guardant’s COVID-19 U.S. Vaccination Policy as a reasonable accommodation.  An employee is considered fully vaccinated against COVID-19 two weeks after receiving the second dose of a two-dose vaccine or one dose of a single-dose vaccination. Acceptable vaccines are approved or under emergency use authorization by the U.S. Food and Drug Administration (FDA) and/or the World Health Organization (WHO). In addition, fully-vaccinated employees will be required to maintain their fully-vaccinated status under this Policy by obtaining, if applicable, any FDA-approved boosters.

Employee may be required to lift routine office supplies and use office equipment.  Majority of the work is performed in a desk/office environment; however, there may be exposure to high noise levels, fumes, and biohazard material in the laboratory environment.  Ability to sit for extended periods of time.

Guardant Health is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

All your information will be kept confidential according to EEO guidelines.

To learn more about the information collected when you apply for a position at Guardant Health, Inc. and how it is used, please review our Privacy Notice for Job Applicants.

#LI-JL1

Privacy Policy